このエントリーをはてなブックマークに追加
ID 62711
フルテキストURL
著者
Fujiwara, Noriko Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Dentistry and Pharmaceutical Sciences, Okayama University Graduate School of Medicine
Watanabe, Mayu Department of Primary Care and Medical Education, Dentistry and Pharmaceutical Sciences, Okayama University Graduate School of Medicine
Katayama, Akihiro Diabetes Center, Okayama University Hospital
Noda, Yohei Department of Otolaryngology-Head and Neck Surgery, Dentistry and Pharmaceutical Sciences, Okayama University Graduate School of Medicine
Eguchi, Jun Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Dentistry and Pharmaceutical Sciences, Okayama University Graduate School of Medicine Kaken ID researchmap
Kataoka, Hitomi Department of Primary Care and Medical Education, Dentistry and Pharmaceutical Sciences, Okayama University Graduate School of Medicine
Kagawa, Shunsuke Minimally Invasive Therapy Center, Okayama University Hospital ORCID Kaken ID publons researchmap
Wada, Jun Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Dentistry and Pharmaceutical Sciences, Okayama University Graduate School of Medicine ORCID Kaken ID publons researchmap
抄録
Immune checkpoint inhibitor-induced diabetes mellitus is a rare immune-related adverse event. This report illustrates clinical data and insulin secretory ability before and after the onset of immune checkpoint inhibitor-induced diabetes.
キーワード
C-peptide
diabetes mellitus
immune checkpoint inhibitor
insulin secretion
発行日
2021-09-07
出版物タイトル
Clinical Case Reports
9巻
9号
出版者
Wiley
開始ページ
e04574
ISSN
2050-0904
資料タイプ
学術雑誌論文
言語
英語
OAI-PMH Set
岡山大学
著作権者
© 2021 The Authors.
論文のバージョン
publisher
PubMed ID
DOI
Web of Science KeyUT
関連URL
isVersionOf https://doi.org/10.1002/ccr3.4574
ライセンス
https://creativecommons.org/licenses/by-nc-nd/4.0/
オープンアクセス(出版社)
OA